Aiolos Bio
3 known investors
Aiolos Bio is a biopharma company that discovers, develops, and delivers medicines and vaccines across respiratory, immunology, inflammation, oncology, HIV, and infectious diseases.
Investors · 3
Companies House · registry record
View on Companies House ↗- Registered name
- AIOLOS BIO LIMITED
- Company number
- 14956089
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 23 Jun 2023
- Registered office
- 79 New Oxford Street, London, WC1A 1DG
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Previous names
- ONE BIOTECH LIMITED (2023–2023)
- Accounts
- last made up to 31 Dec 2024 · next due 30 Sept 2026
- Confirmation statement
- last made up to 16 Apr 2026 · next due 30 Apr 2027
Current officers · 2
- Peter Kenneth Hopkins — director, appointed 14 Feb 2024
- Edinburgh Pharmaceutical Industries Limited — corporate director, appointed 14 Feb 2024
Source: Companies House public register · retrieved 24 Jul 2026. Contains public sector information licensed under the Open Government Licence v3.0.